SCHEMBL20155955

SCHEMBL20155955

N#Cc1ccccc1-c1ccc2c(c1)c1cc(-c3ccccc3C#N)ccc1n2-c1ccc(-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)c(C#N)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.45
ALDH1A1 P00352 5/20 0.41
HPGD P15428 4/20 0.41
MAPK1 P28482 3/20 0.41
LMNA P02545 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TRPA1 O75762 1/20 0.39
CYP1A2 P05177 6/20 0.38
CYP3A4 P08684 6/20 0.38
HSD17B10 Q99714 4/20 0.38
CLK4 Q9HAZ1 3/20 0.38
GABRG2 P18507 4/20 0.38
GABRB3 P28472 4/20 0.38
GABRA5 P31644 3/20 0.38
GABRA3 P34903 3/20 0.38
ALOX5AP P20292 1/20 0.37
FEN1 P39748 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
USP2 O75604 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20150435 0.97 NR3C1 (0.43) NR3C1ALDH1A1HPGDMAPK1LMNA
SCHEMBL20156187 0.93 ALDH1A1 (0.44) NR3C1ALDH1A1HPGDMAPK1LMNA
SCHEMBL27016143 0.93 ALDH1A1 (0.39) NR3C1ALDH1A1HPGDMAPK1LMNA
SCHEMBL24125852 0.92 NR3C1 (0.44) NR3C1ALDH1A1HPGDMAPK1LMNA
SCHEMBL20155956 0.92 NR3C1 (0.46) NR3C1ALDH1A1HPGDMAPK1LMNA
SCHEMBL20155934 0.92 ALDH1A1 (0.43) NR3C1ALDH1A1HPGDMAPK1LMNA
SCHEMBL27016138 0.92 ALDH1A1 (0.38) NR3C1ALDH1A1HPGDMAPK1LMNA
SCHEMBL20155969 0.90 ALDH1A1 (0.41) NR3C1ALDH1A1HPGDMAPK1LMNA
SCHEMBL20150444 0.90 ALDH1A1 (0.41) NR3C1ALDH1A1HPGDMAPK1LMNA
SCHEMBL27016142 0.90 NR3C1 (0.37) NR3C1ALDH1A1HPGDMAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-09-24 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, EPCAM, F12 NR3C1 4383/4885ALDH1A1 387/4885HPGD 2446/4885
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, EPCAM, F12 NR3C1 4383/4885ALDH1A1 387/4885HPGD 2446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.